5 Things to Consider when Developing Clinical Biomarkers | Immunology Diagnosis | Scoop.it
From www.linkedin.com - March 5, 2015 6:21 PM
Developing cellular biomarkers is particularly challenging when it comes to biomarker validation, because flow cytometry has limitations regarding sample stability and multiplexing. Moreover, the development of highly multiplex flow cytometry assays is time-consuming and expanding existing panels can be quite cumbersome. ChipCytometry is a new, imaging based, cytometry technology bridging the gap between biomarker discovery and clinical biomarker validation through flexible “sequential singleple